Stocks and Investing Stocks and Investing
Thu, November 10, 2022

Andrew Berens Maintained (VIRX) at Buy and Held Target at $11 on, Nov 10th, 2022


Published on 2024-10-28 00:03:58 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Securities, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $11 on, Nov 10th, 2022.

Andrew, nor any peers, have made any analyst calls on VIRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources